47
Growth Score
pts
Heat Score
8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
405415
Shifa Biomedical is a drug discovery company that develops drugs for the treatment of cardiovascular disease.
- Sherin Abdel-Meguid: Founder and PresidentPast Role: Monsanto, Senior Group Leader
- Nabil Elshourbagy: Vice President
About the Company
Shifa Biomedical Corporation is a drug discovery company in Malvern Pennsylvania. It is a privately-held biopharmaceutical company dedicated to the cost-effective development of drugs for the treatment of cardiovascular disease.
Incorporated in 2006, Shifa has recognized expertise for the discovery of small molecule drugs, including pharmaceutical
experience guided by biochemical, cell-based, and virtual screening. Shifa scientists exploit molecular biology, biochemistry, crystallography and medicinal, computational, and combinatorial chemistry. Shifa is led by a highly experienced team of scientists with extensive expertise in early-stage drug discovery.
